v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Class A common stock
Total Stockholders' Equity
Class A common stock
Common Stock
Class A common stock
Additional Paid-In Capital
Class A common stock
Unvested restricted stock
Total Stockholders' Equity
Unvested restricted stock
Additional Paid-In Capital
Unvested restricted stock
Class B common stock
Common Stock
Class B common stock
Noncontrolling Interests
Class B common stock
Total Stockholders' Equity
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Noncontrolling Interests
Total
Beginning balance at Dec. 31, 2024   $ 1,031           $ 162     $ 793,520 $ 998,474 $ (206,147) $ 122,014 $ 915,534
Beginning balance (in shares) at Dec. 31, 2024   103,069,732           16,221,101              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Equity-based compensation                     3,009 3,009   472 3,481
Issuance of restricted shares   $ 7                 768 761   (768)  
Issuance of restricted shares (in shares)   740,084                          
Cashless exercise of options                     216 216     216
Cashless exercise of options (in shares)   24,943                          
Repurchase of common stock   $ (5)                 (5,865) (5,860)   (502) (6,367)
Repurchase of common stock ( in shares)   (544,287)                          
Performance shares vested   $ 6                 406 400   (406)  
Performance shares vested (in shares)   594,295                          
Contributions from noncontrolling interests                           2,875 2,875
Dividend and distribution declared $ (7,029)   $ (7,029) $ (7,029) $ (186) $ (186) $ (186)   $ (1,135) $ (1,135)          
Net income                     8,239   8,239 1,321 9,560
Ending balance at Mar. 31, 2025   $ 1,039           $ 162     793,078 989,785 (197,908) 123,871 916,949
Ending balance (in shares) at Mar. 31, 2025   103,884,767           16,221,101              
Beginning balance at Dec. 31, 2025   $ 1,049           $ 162     805,616 989,329 (184,924) 121,451 927,067
Beginning balance (in shares) at Dec. 31, 2025   104,884,902           16,221,101              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of shares for underwritten offering   $ 157                 185,118 184,961   8,289 193,407
Issuance of shares for underwritten offering (in shares)   15,784,315                          
Equity-based compensation                     5,119 5,119   706 5,825
Issuance of restricted shares   $ 9                 787 778   (787)  
Issuance of restricted shares (in shares)   864,675                          
Cashless exercise of options                     598 598     598
Cashless exercise of options (in shares)   68,611                          
Repurchase of common stock   $ (6)                 (7,542) (7,536)   (674) (8,216)
Repurchase of common stock ( in shares)   (601,250)                          
Restricted shares forfeited                     (6) (6)   6  
Restricted shares forfeited (in shares)   (6,636)                          
Performance shares vested   $ 9                 530 521   (530)  
Performance shares vested (in shares)   852,901                          
Dividend and distribution declared $ (7,185)   $ (7,185) $ (7,185) $ (160) $ (160) $ (160)   $ (1,135) $ (1,135)          
Net income                     8,606   8,606 826 9,432
Ending balance at Mar. 31, 2026   $ 1,218           $ 162     $ 991,481 $ 1,166,419 $ (176,318) $ 128,152 $ 1,119,633
Ending balance (in shares) at Mar. 31, 2026   121,847,518           16,221,101